Table 1 Association between PD-1/PD-L1 expression and clinical data
Group | Category | n | PD1 [mean (sd)] | PD1 P | PDL1 [mean (sd)] | PDL1 P |
|---|---|---|---|---|---|---|
ER | Negative | 212 | 4.35 (7.21) | < 0.001 | 4.35 (7.84) | < 0.001 |
ER | Positive | 727 | 1.82 (3.55) | 2.28 (3.19) | ||
Her2 | Negative | 495 | 2.54 (5.23) | 0.27 | 3.04 (5.62) | 0.39 |
Her2 | Positive | 152 | 2.04 (3.38) | 2.62 (4.13) | ||
PR | Negative | 308 | 3.47 (6.27) | < 0.001 | 3.41 (6.43) | 0.003 |
PR | Positive | 628 | 1.86 (3.68) | 2.42 (3.59) | ||
Histological type | Infiltrating ductal carcinoma | 790 | 2.48 (5.67) | 0.274 | 2.94 (5.77) | 0.278 |
Histological type | Infiltrating lobular carcinoma | 205 | 2.58 (4.82) | 2.36 (2.39) | ||
Histological type | Other type | 107 | 1.62 (4.44) | 2.42 (5.08) | ||
Therapy type | Chemotherapy | 385 | 3.14 (6.96) | 0.015 | 3.38 (6.38) | 0.004 |
Therapy type | Hormone therapy | 365 | 1.96 (4.24) | 2.18 (2.82) | ||
Therapy type | Other therapy | 31 | 2.02 (2.24) | 2.56 (2.19) |